The improved long-term survival of adolescents and young women treated for cancer has
resulted in an increased focus on the effects of chemotherapy on ovarian function and its …

Background Epigenomic dysregulation has been linked to solid tumour malignancies,
including ovarian cancers. Profiling of re-programmed enhancer locations associated with …

Background Treatment of advanced epithelial ovarian cancer results in a relapse rate of 75%.
Early markers of response would enable optimization of management and improved …

Background Ovarian cancer has a specific unmet clinical need, with a persistently poor 5-year
survival rate observed in women with advanced stage disease warranting continued …

Background Diffusion-weighted magnetic resonance imaging (DW-MRI) potentially interrogates
site-specific response to neoadjuvant chemotherapy (NAC) in epithelial ovarian cancer (…

Objective To evaluate the accuracy of the risk of malignancy index (RMI) which combines
serum CA-125 levels, ultrasound score, and menopausal state, in discriminating between …

Simple Summary Endometrial cancer (EC) is diagnosed in almost 400,000 women every year
globally and is the sixth most common cancer in women. When diagnosed early, treatment …

Objectives The study aimed to assess if specialised healthcare service interventions in Wales
benefit the population equitably in work commissioned by the Welsh Health Specialised …

Background: Ovarian cancer (OC) is amongst the most lethal of common cancers in women.
Lack of specific symptoms in the early stages, OC is predominantly diagnosed late when the …

Simple Summary There is no consensus on the optimal treatment strategy for locally advanced
vulvar cancer. In this paper, we aimed to highlight the outcomes from pelvic exenteration …